Spinnaker Trust Vertex Pharmaceuticals Inc Transaction History
Spinnaker Trust
- $1.61 Billion
- Q3 2024
A detailed history of Spinnaker Trust transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Spinnaker Trust holds 1,210 shares of VRTX stock, worth $517,880. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,210
Previous 1,210
-0.0%
Holding current value
$517,880
Previous $567,000
0.88%
% of portfolio
0.03%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding VRTX
# of Institutions
1,712Shares Held
222MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$11.5 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.91 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.12 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.06 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.85 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $110B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...